Level Four Advisory Services’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.1K | Hold |
10,000
| – | – | ﹤0.01% | 782 |
|
|
2025
Q1 | $22.5K | Hold |
10,000
| – | – | ﹤0.01% | 749 |
|
|
2024
Q4 | $35K | Hold |
10,000
| – | – | ﹤0.01% | 749 |
|
|
2024
Q3 | $42.1K | Hold |
10,000
| – | – | ﹤0.01% | 760 |
|
|
2024
Q2 | $36K | Sell |
10,000
-10,000
| -50% | -$36K | ﹤0.01% | 732 |
|
|
2024
Q1 | $46.2K | Hold |
20,000
| – | – | ﹤0.01% | 758 |
|
|
2023
Q4 | $46.2K | Hold |
20,000
| – | – | ﹤0.01% | 754 |
|
|
2023
Q3 | $25.8K | Hold |
20,000
| – | – | ﹤0.01% | 730 |
|
|
2023
Q2 | $26.4K | Hold |
20,000
| – | – | ﹤0.01% | 792 |
|
|
2023
Q1 | $14.1K | Hold |
20,000
| – | – | ﹤0.01% | 752 |
|
|
2022
Q4 | $15K | Hold |
20,000
| – | – | ﹤0.01% | 669 |
|
|
2022
Q3 | $17K | Hold |
20,000
| – | – | ﹤0.01% | 539 |
|
|
2022
Q2 | $22K | Hold |
20,000
| – | – | ﹤0.01% | 548 |
|
|
2022
Q1 | $22K | Buy |
+20,000
| New | +$22K | ﹤0.01% | 637 |
|